1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adaptimmune Therapeutics PLC (ADAP)

  7. Adaptimmune Therapeutics PLC (ADAP) Financials

ADAP

Adaptimmune Therapeutics PLC
1.10
0.01 (0.92%)
Upgrade to Real-Time

Adaptimmune Therapeutics plc (ADAP) Fundamentals
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.
SHARE INFORMATION
Market CapUS$ 183,488,764
Shares Outstanding165,305,193
Float134,101,658
Percent Float81.12%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 27,148,000
Latest Fiscal EPSUS$ -1.02
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions146
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months9,119,823
Institutional Holdings Percent79.7%
Institutional Sold Previous 3 Months8,558,140
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months19,832,688
Insider Holdings Percent3.2
Insider Sold Previous 3 Months104,348
Insider Shares Owned31,203,535
TRADING INFO
52 Week HighUS$ 2.65
52 Week LowUS$ 1.01
52 Week High ChangeUS$ -50.67
21 Day Moving AverageUS$ 1.3695
21 Day Extended Moving AverageUS$ 1.3111
50 Day Moving AverageUS$ 1.5775
50 Day Extended Moving AverageUS$ 1.4837
200 Day Moving AverageUS$ 1.6891
200 Day Extended Moving AverageUS$ 1.8249
10 Day Average Volume996,331
20 Day Average Volume1,015,583
30 Day Average Volume744,821
50 Day Average Volume573,635
Alpha0.023708
Beta2.2055
Standard Deviation0.473980
R20.062788
7 Day Price ChangeUS$ -0.02
7 Day Percent Change-1.77%
21 Day Price ChangeUS$ -0.54
21 Day Percent Change-32.73%
30 Day Price ChangeUS$ -0.51
30 Day Percent Change-31.48%
Month to Date Price ChangeUS$ -0.66
Month to Date Percent Change-37.29%
Quarter to Date Price ChangeUS$ -0.35
Quarter to Date Percent Change-23.97%
180 Day Price ChangeUS$ -0.22
180 Day Percent Change-16.54%
200 Day Price ChangeUS$ -0.91
200 Day Percent Change-45.05%
Year to Date Price ChangeUS$ -0.35
Year to Date Percent Change-23.97%

Adaptimmune Therapeutics plc (ADAP) Key Ratios

PROFITABILITY
EBIT Margin-1,024.0%
EBITDA Margin-984.9%
Pre-Tax Profit Margin-3,794.7%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 27,148,000
Revenue Per ShareUS$ 0.1755
Revenue (3 Years)US$ -58.06
Revenue (5 Years)US$ -21.94
FINANCIAL STRENGTH
Price to Tangible Book2.20
Total Debt To Equity0.30
Int Coverage0.00
Current Ratio4.00
Leverage Ratio2.90
Quick Ratio3.80
Long Term Debt To Capital0.20
VALUATION MEASURES
PE Ratio-1.50
Enterprise ValueUS$ 15,185,179
Price to Sales6.3236
Price to Free Cash-1.10
PE High Last 5 Years-4.00
Price To Book2.20
Price To Cash Flow127.40
PE Low Last 5 Years-4.20
Price to Tangible Book2.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.70
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-42.87
Return on Equity-119.83
Return on Capital-87.30

Adaptimmune Therapeutics plc (ADAP) Profile

PROFILE INFO
Issue TypeAD
SEC TypeDR
AuditorKPMG LLP
CEOAdrian Rawcliffe
Emplyoees494
Last AuditUQ
CIK0001621227
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address60 Jubilee Avenue
Milton Park
Abingdon, Oxfordshire OX14 4RY
Websitehttps://www.adaptimmune.com
Facsimile+44 1235430001
Telephone+44 1235430000
EmailIR@adaptimmune.com
Your Recent History
NASDAQ
ADAP
Adaptimmun..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 03:39:41